Analysts Set Amdocs Limited (NASDAQ:DOX) Target Price at $92.33

Amdocs Limited (NASDAQ:DOX) has been assigned a consensus recommendation of “Moderate Buy” from the five ratings firms that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $92.3333.

A number of research analysts have recently commented on the stock. Barclays reduced their price target on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, February 4th. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Stifel Nicolaus lowered their price target on Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, February 4th. Wall Street Zen raised Amdocs from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, Wolfe Research restated a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th.

Amdocs Stock Up 1.8%

Shares of NASDAQ DOX opened at $69.71 on Monday. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.23. The company has a market cap of $7.53 billion, a P/E ratio of 13.48, a P/E/G ratio of 1.21 and a beta of 0.42. Amdocs has a 52 week low of $65.74 and a 52 week high of $95.41. The business has a 50-day simple moving average of $76.40 and a two-hundred day simple moving average of $79.92.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. The firm had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.15 billion. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Research analysts anticipate that Amdocs will post 6.21 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be issued a $0.569 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend is Tuesday, March 31st. This is a positive change from Amdocs’s previous quarterly dividend of $0.53. Amdocs’s payout ratio is currently 40.81%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Scotia Capital Inc. grew its stake in shares of Amdocs by 3.5% in the third quarter. Scotia Capital Inc. now owns 4,289 shares of the technology company’s stock worth $352,000 after purchasing an additional 145 shares during the last quarter. Huntington National Bank increased its stake in shares of Amdocs by 5.0% in the 2nd quarter. Huntington National Bank now owns 3,273 shares of the technology company’s stock worth $299,000 after acquiring an additional 155 shares in the last quarter. CENTRAL TRUST Co lifted its holdings in shares of Amdocs by 6.1% during the third quarter. CENTRAL TRUST Co now owns 2,741 shares of the technology company’s stock valued at $225,000 after purchasing an additional 158 shares during the last quarter. WealthCollab LLC boosted its holdings in Amdocs by 94.5% in the third quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock worth $29,000 after acquiring an additional 173 shares in the last quarter. Finally, Rossby Financial LCC increased its holdings in shares of Amdocs by 39.3% during the third quarter. Rossby Financial LCC now owns 620 shares of the technology company’s stock valued at $50,000 after acquiring an additional 175 shares in the last quarter. 92.02% of the stock is currently owned by hedge funds and other institutional investors.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.